Cartesian Therapeutics, Inc. (RNAC): 6 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Dec 8, 2025 | Barabe Timothy C Director | 30,000 | $6.86 | $205.8K | no history |
| Apr 11, 2025 | Springer Timothy A Director, TenPercentOwner | 149,075 | $10.21 | $1.5M | no history |
| Mar 20, 2025 | Springer Timothy A Director, TenPercentOwner | 89,863 | $15.26 | $1.4M | no history |
| Jan 15, 2025 | Springer Timothy A Director, TenPercentOwner | 20,967 | $17.47 | $366.4K | no history |
| Dec 23, 2024 | Springer Timothy A Director, TenPercentOwner | 52,189 | $18.49 | $965.0K | no history |
| Nov 18, 2024 | Springer Timothy A Director, TenPercentOwner | 431,940 | $17.07 | $7.4M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.